Literature DB >> 1240636

The effect of long-term penfluridol treatment on the sensitivity of the dopamine receptors in the nucleus accumbens and in the corpus striatum.

D M Jackson, N E Andén, J Engel, S Liljequist.   

Abstract

The effect of local application of dopamine to the nucleus accumbens or corpus striatum on locomotor activity was studied in rats 4 days after withdrawal from a 6 weeks term of penfluridol medication. The bilateral application of dopamine into the nucleus accumbens of penfluridol-treated rats produced a very marked increase in coordinated locomotor activity which was 3-5 times higher than that of rats not treated with penfluridol. This effect of dopamine in both penfluridol-treated and control rats was antagonized by intraperitoneally administered haloperidol. The bilateral application of dopamine into the corpus striatum of penfluridol-treated animals produced a marked stereotyped behavioural syndrome in all rats studied, whereas no signs of stereotyped behaviour were observed in any of the rats not treated with penfluridol. The results indicate that long-term treatment of rats with the dopamine receptor blocking agent penfluridol produces an increase in the sensitivity of the dopamine receptors in the nucleus accumbens and corpus striatum and that the nucleus accumbens may play a role in locomotor activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1240636     DOI: 10.1007/bf00429053

Source DB:  PubMed          Journal:  Psychopharmacologia


  24 in total

1.  Long-term L-dopa pretreatment of mice: central receptor subsensitivity or supersensitivity?

Authors:  R C Bailey; D M Jackson; P U Bracs
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

2.  Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation.

Authors:  A Dolphin; M Christina; M C Sawaya; P Jenner; C D Marsden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

3.  The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.

Authors:  R Dunstan; D M Jackson
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

4.  Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.

Authors:  R Dunstan; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

5.  Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.

Authors:  U Strömbom; T H Svensson; D M Jackson; G Engström
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 6.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

7.  The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.

Authors:  R Dunstan; D M Jackson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

8.  Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.

Authors:  B Costall; A M Domeney; R J Naylor; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

9.  Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease.

Authors:  M Goldstein; A Lieberman; J Pearson
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.

Authors:  G Stock; J Steinbrenner; P Kummer
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.